Skip to main content

Solventum Corporation (SOLV)

New York Stock Exchange Healthcare Medical - Care Facilities
54.1Fair

ValueMarkers Composite Index

Top 51%#22,322 of 45,176
Undervalued

65% below intrinsic value ($179)

UndervaluedFair ValueOvervalued
Piotroski
7/9
Strong
Beneish
-2.71
Low Risk
Altman
2.04
Grey Zone
DCF Value
$179
Undervalued
ROIC
17.8%
Strong
P/E
7.3
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

CEO: Bryan C. Hanson22,000 employeesUSwww.solventum.com

Deep Dive Analysis

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.